Aton (BST:3HB)

Market Cap	10.77M +65.0%
Revenue (ttm)	661.00K +7.7%
Net Income	-962.00K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0128
Previous Close	0.0128
Day's Range	0.0122 - 0.0140
52-Week Range	0.0002 - 0.0258
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 13
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 3HB

Financial Performance

In 2025, Aton's revenue was 661,000, an increase of 7.65% compared to the previous year's 614,000. Losses were -962,000, -12.62% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error